QuantumGenic™ is building a next-generation platform for brain health and neuroregeneration. We focus on supporting recovery, resilience, and long-term cognitive performance for people affected by neurodegeneration, brain injury, and cognitive decline.

Our approach combines proprietary formulations, targeted delivery systems, AI, and a staged commercialization model that starts with direct-to-consumer offerings and expands through practitioner/provider channels and, over time, B2B licensing partnerships.

We are an early-stage U.S. based company currently advancing its core platform and preparing for initial commercialization.
What we’re focused on  
– Brain health and neuroregeneration for both high-need and broader populations  
– Direct-to-consumer launch followed by practitioner and provider distribution  
– Future B2B licensing of our proprietary delivery platform to strategic partners
Who we’d like to connect with  
– Strategic partners in brain health, neuroscience, wellness, and healthcare  
– Investors interested in early-stage brain health and neuroregeneration platforms  
– Clinicians, practitioners, and operators aligned with our mission

For investor or partnership conversations, please message us on LinkedIn or email Marcus Ng, Chief Revenue Officer.

QuantumGenic™

Org chart

Teams

Offices

QuantumGenic™

Org chart

Teams

Offices

Related companies